Nanograb

Nanograb is a biotech company in San Francisco, United States, founded in 2023. It has raised $500K across 2 rounds, most recently a Venture Round in June 2023.

AI-generated binders for targeted drug delivery

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$500K
Last Round
Venture RoundJun 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Nanograb uses AI to design combinations of binders that target drugs to specific areas of the body. Its NGX1 platform combines biophysics-informed AI with multivalent targeting to deliver mRNA to specific cell types. The approach coats lipid nanoparticles with multiple short peptides for targeting, and public biopharma partners are paying for early access.

Summary

It lists 1–10 employees. It has raised $500K in total across 2 rounds, most recently a Venture Round in Jun 2023. Investors include Sterling Road and Y Combinator.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundJun 2023

Sign up to see all 2 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nanograb on Indexed.vc
<a href="https://indexed.vc/companies/nanograb"><img src="https://indexed.vc/api/badge/company/nanograb" alt="Nanograb on Indexed.vc" width="260" height="76" /></a>